Flowers of Astragalus membranaceus var. mongholicus as a Novel High Potential By-Product: Phytochemical Characterization and Antioxidant Activity

Abstract

The root of Astragalus membranaceus var. mongholicus is one of the most popular herbal medicines worldwide. In order to increase the yield of underground roots of A. membranaceus var. mongholicus, its flowers (AMF) have often been removed in their flowering stage, which produces the flowers as waste being discarded. To explore its phytochemicals and potential value for utilization, the antioxidant activities of extracts from AMF were evaluated by a free radical scavenging assay and reducing power assay. The total phenols and flavonoids, as well as the individual compounds, in different extracts of AMF were also investigated. The results showed that the extract ME obtained from AMF through macroporous resins separation exhibited strong antioxidant activities, which were close to those of positive control BHT. ME was rich in phenolic acids and flavonoids, and the contents reached 108.42 mg gallic acid equivalents/g and 265.70 mg rutin equivalents/g, respectively. A total of 31 compounds, including four phenolic acids, nineteen flavonoids, three isoflavones, two pterocarpans, and three saponins, were identified using UPLC-QTOF-MS in ME. Quantitative analysis of sixteen components in the extracts of AMF showed that flavonoids were the predominant constituents, especially for the compounds of hyperoside, rutin, and isorhamnetin-3-O-β-d-glucoside.

1. Introduction

Astragalus membranaceus and its variety A. membranaceus var. mongholicus, as the perennial herbs in the Leguminosae family, are mainly distributed in Northeast, North, and Northwest China, as well as in Mongolia and Korea [1]. Their root (Astragali Radix), known as Huangqi in China, is one of the most popular herbal medicines worldwide, with immunomodulating [2,3] antihyperglycemic [4], antiinflammatory [5], antioxidant [6,7], and antiviral activities. As one of the most important Qi tonifying adaptogenic herbs in Traditional Chinese Medicine, Astragali Radix has been utilized as a crude drug, as well as food, in China for thousands of years [8].

In recent years, owing to the increasing demand for its use as a raw material for health food, the natural resources of Astragali Radix have been diminishing. At present, the resources of Astragali Radix mainly originate from cultivated plants in China [9]. In order to increase the yield of its underground roots, the flowers of A. membranaceus and A. membranaceus var. mongholicus (AMF) are often removed in their flowering stages, which produces large amounts of the flowers as waste being discarded and has caused a great waste of plant resources [10,11]. Thus, it is necessary to transform the flower waste of the processed crop product into ecologically friendly or sustainable material suitable for industrial purposes, in particular, for health products that are in high demand.

According to previous studies, the flowers of some species in Astragalus genus are reported to contain a relatively high amount of flavonoids, triterpenoid saponins, phenolic acids, and volatile compounds [12,13,14]. Besides, flavonoids, sugars, amino acids, and triterpenoid saponins were definitely detected in the flower of A. membranaceus [15,16,17]. Owing to the activities of the above compounds previously reported, AMF could be a promising raw material of health products. However, the available information on its bioactivity is rather scarce.

It is well-known that free radicals are considered to be responsible for damage to lipids, proteins, and nucleic acids in cells, which play a key role in the pathogenesis of various diseases [18]. Thus, exploring the natural antioxidants for use in pharmaceutical or food products has gradually attracted attention in recent years in order to limit the use of synthetic antioxidants, due to side effects. As a Chinese tonic medicine, the roots of A. membranaceus and A. membranaceus var. mongholicus have shown obvious preventive effects on tissue injury via antioxidant mechanisms [19], while little information about the antioxidant activity was found for their flowers.

Accordingly, the purpose of this study was to verify the antioxidant activity and its related chemical constituents in AMF. Their antioxidant activities were investigated by a free radical scavenging assay and reducing power assay. The total phenols and flavonoids, as well as the individual compounds, in the extracts of AMF were also investigated, and the results can demonstrate the possibility of utilizing the AMF as a novel by-product in pharmaceutical, food, or personal care applications.

2. Results and Discussion

2.1. Antioxidant Activity of the Extracts from AMF

To screen the potential activity of AMF, the antioxidant capacity of the samples was determined using DPPH and ABTS radical scavenging activity, as well as FRAP assays. The results are presented in Figure 1. As shown, the antioxidant capacity of EE (ethanol extract) was significantly higher than that of AE (aqueous extract). Further separation of EE was performed on an AB-8 macroporous resin column, and the three chemical fractions LE (freeze-dried powder of 10% eluent), ME (freeze-dried powder of 50% eluent), and HE (freeze-dried powder of 90% eluent) were obtained with different ratios (10%, 50%, and 90%, v/v) of ethanol in water, and their antioxidant activities were evaluated.

As shown in Figure 1A,B, the ability of AMF extracts to scavenge free ABTS and DPPH radicals showed a growing trend with increasing sample concentration. The ME fraction showed strong DPPH radical-scavenging activity due to its excellent IC₅₀ value (35.10 μg/mL) compared to that of BHT (25.28 ± 0.59 μg/mL) (Figure 1C). The results (Figure 1C) of the ABTS test also showed that ME exhibited the best value (22.02 μg/mL) compared to the IC₅₀ value of BHT (17.03 ± 0.75 μg/mL). Compared to ME, both LE and HE displayed lower scavenging activity of DPPH and ABTS free radicals, with the IC₅₀ values all being higher than 150 μg/mL. In the FRAP assay (Figure 1D), most of the fractions exhibited dose-dependent Fe³⁺ reducing power, and ME, once again, exhibited the highest reducing ability (3.00 ± 0.13 μmol Fe²⁺/g), which was close to that of positive control BHT (5.68 ± 0.62 μmol Fe²⁺/g), while only 0.41 ± 0.02 μmol Fe²⁺/g and 0.78 ± 0.03 μmol Fe²⁺/g were found for LE and HE, respectively.

On the basis of the above findings, the chemical fraction of ME from AMF seems to be attractive as an important source of antioxidants for the food and pharmaceutical industries.

2.2. Extraction Yields, Total Phenols, and Flavonoids Contents

It is known that phenols and flavonoids, as major groups of polyphenolic compounds, have a strong relationship with the antioxidant activities of medicinal plants [20]. Thus, the contents of total phenols and flavonoids in AMF extracts, including EE, LE, ME, and HE, were determined by spectroscopic methods, and the results are presented in Figure 2. The TPC values for the four fractions range from 12.29 ± 0.52 mg to 108.42 ± 0.89 mg chlorogenic acid equivalents (CAE)/g dried extract, while their TFC values range from 6.58 ± 0.39 mg to 265.71 ± 21.51 mg rutin equivalents (RE)/g dried extract. The highest TPC and TFC values were observed for the ME fraction, which was in agreement with the results of the antioxidant assay, indicating that there could be a positive correlation between them.

2.3. Characterization of Compounds in AMF Extract by UPLC-QTOF-MS

The characterization of the compounds, as performed by UPLC-DAD/QTOF-MS analysis, was only conducted in the ME extract, owing to its best results in the antioxidant activity assays. The detected and identified compounds are listed in

Table 1. Compounds identified in ME of AMF by UPLC-Q-TOF MS analysis.

No.	tR (min)	Molecular Formula	[M + H]+ (Error, ppm)	Fragment Ions in Positive (+) Ion Mode	[M − H]− (Error, ppm)	Fragment Ions in Negative (−) Ion Mode	λmax (nm)	Identity
1	0.675	C8H8O4	169.0497 [M + H]+ (−2.4)		167.0339 [M − H]− (−3.0)		290	vanillic acid a
2	1.371	C7H6O4			153.0192 [M − H]− (2.6)	109.0335 [M − H − CO2]−	310	protochatechuic acid a
3	2.424	C9H8O4	181.0503 [M + H]+ (3.3)		179.0346 [M − H]− (1.1)	135.0482 [M − H − CO2]−	240, 320	caffeic acid a
4	3.223		927.1859 [M + H]+	765.1391 [M + H − 162]+ 603.0392 [M + H − 162 − 162]+ 465.1044, 301.0693	925.1574	625.1326, 461.1058, 299.0533		Unidentified-O-hexoside-hexoside
5	3.585		481.0921 [M + H]+	319.0419 [M + H − 162]+ 303.0485	479.0791 [M − H]−			Unidentified-O-hexoside
6	3.766	C26H28O16	597.1466 [M + H]+ (1.7)	465.1012 [M + H − 132]+ 303.0500 [M + H − 132 − 162]+	595.1283 [M − H]− (−2.7)		255, 352	quercetin-O-hexoside -pentoside
7	4.011	C27H30O16	611.1594 [M + H]+ (−2.9)	465.0987 [M + H − rha]+ 303.0524 [M + H − glc − rha]+	609.1438 [M − H]− (−3.0)		255, 352	rutin a
8	4.207	C26H28O16	597.1456 [M + H]+ (0.0)	465.0993 [M + H − 132]+ 303.0482 [M + H − 162 − 132]+ 209.1519, 191.1408	595.1277 [M − H]− (−3.7)		254, 351	quercetin-O-hexoside -pentoside
9	4.310	C10H10O4			193.0515 [M − H]− (4.1)	178.0311 [M − H − CH3]− 134.0392 [M − H − CO2 − CH3]−	320	ferulic acid a
10	4.462	C22H22O10	447.1312 [M + H]+ (4.7)	285.0738 [M + H − glc]+			260, 290	calycosin-7-O-β-d-glucoside a
11	4.614	C21H20O12	465.1029 [M + H]+ (−0.9)	303.0492 [M + H − gal]+ 287.0528	463.0806 [M − H]− (−3.2)		256, 352	hyperoside a
12	4.780	C21H20O12	465.1020 [M + H]+ (−2.8)	303.0477 [M + H − glc]+	463.0867 [M − H]− (−2.2)	301.0321 [M − H − glc]−	255, 352	isoquercitrin a
13	5.020	C28H32O16	625.1775 [M + H]+ (1.0)	647.1636 [M + Na]+ 479.1188 [M + H − rha]+ 317.0630 [M + H − glc − rha]+ 303.0475, 197.1146	623.1603 [M − H]− (−1.4)	609.1362 [M − CH3]− 463.0808 [M − CH3 − rha]−		isorhamnetin 3-O-rutinoside
14	5.324		941.1999 [M + H]+	779.1476 [M + H − 162]+; 617.1019 [M + H − 162 − 162]+ 697.5236, 479.1232, 317.0638, 303.0507				isorhamnetin-O-hexoside-hexoside derivative
15	5.427	C24H22O15	551.1027 [M + H]+ (−1.8)	303.0479, 287.0526, 273.0385	549.0860 [M − H]− (−3.6)	505.0948 [M − H − CO2]− 301.0316	255, 352	quercetin-O-malonyl-hexoside
16	5.862	C21H20O11	449.1079 [M + H]+ (−1.1)	287.0550 [M + H − glc]+, 229.0483	447.0943 [M − H]− (3.1)	285.0388 [M − H − glc]−	265, 346	astragalin a
17	6.152	C22H22O12	479.1201 [M + H]+ (2.3)	317.0593 [M + H − glc]+	477.1026 [M − H]− (−1.5)	315.0468 [M − H − glc]−	254, 352	isorhamnetin-3-O-β-d-glucoside a
18	6.304		679.5200 [M + H]+	701.4979 [M + Na]+ 566.4278, 453.3440, 317.0627, 303.0491, 287.0552, 273.0742	677.4871 [M − H]−	723.4912 [M + HCOO]− 477.0983		Unidentified
19	6.740		535.1082 [M + H]+	557.0948 [M + Na]+ 517.0905 [M + H − H2O]+ 462.3415	533.0818 [M − H]−	489.0993 [M − H − CO2]− 285.0410	265, 344	flavonoid
20	7.117		792.5888 [M + H]+	814.5846 [M + Na]+, 679.5115, 565.1169, 396.7961, 317.0635	790.5735 [M − H]−	836.5712 [M + HCOO]− 519.1112, 315.0487	254, 354	flavonoid
21	7.254	C22H22O11	463.1234 [M + H]+ (−1.3)	301.0672 [M + H − glc]+ 286.1731 [M + H − glc − CH3]+	461.1041 [M − H]− (−2.8)	299.0568 [M − H − glc]−	238, 266, 332	pratensein-7-O-β-d-glucoside
22	7.371	C33H40O21	773.2129 [M + H]+ (−1.4)	795.1703 [M + Na]+ 611.6411 [M + H − 162]+ 465.1052 [M + H − 162 − 146]+ 303.0500 [M + H − 162 − 146 − 162]+	771.1979W [M − H]− (−0.6)		254, 356	quercetin-O-rutinoside-hexoside
23	7.812		905.6908 [M + H]+	927.6686 [M + Na]+, 679.5251, 566.4298, 453.3409, 341.2460	903.6592 [M − H]−	949.6523 [M + HCOO]− 813.4478, 519.1101, 343.2118		Unidentified
24	8.370		1018.7797 [M + H]+	1040.7581 [M + Na]+ 509.8839, 341.2454 288.1595		1062.7168, 741.1525 623.1522, 515.2469 343.2078		Unidentified
25	8.929	C15H10O7	303.0501 [M + H]+ (−1.3)	285.0747 [M + H − H2O]+	301.0347 [M − H]− (−0.3)	283.0600 [M − H − H2O]−	254, 366	quercetin a
26	9.061	C16H12O5	285.0756 [M + H]+ (−2.5)	270.0500 [M + H − CH3]+			250, 190	calycosin a
27	9.328	C22H22O12	479.1185 [M + H]+ (−1.0)	317.0656 [M + H − 162]+ 299.0548, 183.0756, 163.0363	477.1028 [M − H]− (−1.0)	315.0489 [M − H − 162]−	258, 350	isorhamnetin-O-hexoside
28	9.380	C23H26O10	463.1592 [M + H]+ (−2.6)	301.0672 [M + H − glc]+			256, 354	(−)-methylinissolin-3-O-β-d-glucoside a
29	9.857		565.1182 [M + H]+	419.3312 (146) 317.0627, 243.0627	563.0993 [M − H]−	519.1140 [M − H − CO2]−	255, 353	Unidentified-O-rhamnoside
30	10.186	C31H34O18	695.1833 [M + H]+ (1.4)	717.1677 [M + Na]+ 549.1226 [M + H − 146]+ 463.1245 [M + H − 146 − 86]+, 301.0694 [M + H − 146 − 86 − 162]+	693.1659 [M − H]− (1.2)	649.1680 [M − H − CO2]− 461.1049 [M − H − 146 − 86]−	266, 347	rhamnocitrin-O-malonyl-glucoside-rhamnoside
31	10.438	C22H22O11	463.1233 [M + H]+ (−1.5)	485.1034 [M + Na]+ 301.0672 [M + H − 162]+	461.1075 [M − H]− (−2.0)	299.0542 [M − H − glc]−	266, 347	rhamnocitrin-O-hexoside
32	10.678		633.3999 [M + H]+	655.1724 [M + Na]+ 615.3941 [M + H − H2O]+; 453.3354 [M + H − 162 − H2O]+ 597.3831, 435.3251, 301.0700				Unidentified-O-hexoside
33	10.947	C15H10O6	287.0549 [M + H]+ (−2.4)		285.0395 [M − H]− (−1.4)			kaempferol a
34	11.018	C25H24O14	549.1242 [M+H]+ (−0.4)	301.0688 [M + H − 162 − 86]+ 167.0326	547.1067 [M − H]− (−3.8)	503.1147 [M − H − CO2]− 299.0634 [M − H − 162 − 86]−	266, 347	rhamnocitrin-O-malonyl-hexoside
35	11.229	C25H28O11	505.1710 [M + H]+ (0.0)	301.0688 [M + H − glc − 42]+ 286.0468, 167.0296	503.1541 [M − H]− (−2.4)		265, 346	9,10-diMP-3-O-acetyl-glucoside
36	11.295	C16H12O7	317.0658 [M + H]+ (−0.9)	287.0431	315.0609 [M − H]− (1.3)	300.0350		isorhamnetin
37	11.520		797.4355 [M + H]+	819.4246 [M + Na]+ 647.3790, 629.3679, 453.3352, 301.0690	795.4099 [M − H]−	699.4210		Unidentified-O-penoside
38	11.643	C43H70O15	827.4764 [M + H]+ (−3.5)	849.4391 [M + Na]+ 647.3793 [M + H − glc]+ 629.3701 [M + H − glc − H2O]+	825.4608 [M − H]− (−3.4)	697.4040 327.2169		isoastragaloside II a
39	11.765		437.3441 [M + H]+	455.3521 [M + Na]+ 419.3271, 401.3217, 301.0702				Unidentified
40	12.490		637.4607 [M + H]+	659.4114 [M + Na]+ 601.4108, 421.3460, 249.1829	635.4064 [M − H]−	681.4106 [M + HCOO]− 329.2305		Unidentified
41	12.701		795.4209 [M + H]+	817.4014 [M + Na]+ 627.3550, 609.3422, 469.3301, 451.3196, 343.1530, 311.2187 253.2164, 217.1928	793.3873 [M − H]−	287.2206		Unidentified
42	12.818		825.4285 [M + H]+	847.4200 [M + Na]+ 627.3531, 609.3378, 469.3327, 317.0642	823.3981 [M − H]−	677.3810 [M − H − 146]− 631.3703, 315.0492		Unidentified-O-rhamnoside
43	13.181		695 [M + H]+	717.4201 [M + Na]+ 659.4115, 497.3633, 479.3441	693.4111 [M − H]−	739.4180 [M + HCOO]−		Unidentified
44	13.558		635 [M + H]+	657 [M + Na]+ 617.4112, 599.3976, 437.3422, 419.3292, 401.3216	633.3881 [M − H]−	679.3937 [M + HCOO]−		Unidentified
45	13.710		819.3751 [M + H]+	837.3528 [M + Na]+ 798.4721, 745.4219, 727.4098, 685.3970, 667.3876, 497.3634				Unidentified
46	13.906		957.5087 [M + H]+	979.4908 [M + Na]+ 811.4536 [M + H − 146]+				Unidentified-O-rhamnoside
47	14.130	C46H72O18	913.4787 [M + H]+ (−1.1)	935.5103 [M + Na]+ 895.5112 [M + H − H2O]+	911.4661 [M − H]− (2.3)			malonylastragaloside II isomer
48	14.160	C48H78O18	943.5286 [M + H]+ (2.1)	965.5129 [M + Na]+ 797.4725 [M + H − rha]+ 635.4149 [M + H − glc − rha]+ 617.4098 [M + H − glc − rha − H2O]+ 599.3946 [M + H − glc − rha − 2H2O]+ 441.3738, 423.3643, 405.3457, 203.1721	941.5108 [M − H]− (−0.2)			soyasaponin I a
49	14.327	C16H12O6	301.0706 [M + H]+ (−2.0)		299.0549 [M − H]− (−2.3)	284.0317 [M − H − CH3]−	228	rhamnocitrin a
50	16.908		781.4708 [M + H]+	803.4598 [M + Na]+ 763.4578 [M + H − H2O]+ 601.4130 [M + H − 162 − 18]+	779.4440 [M − H]−			Unidentified-O-hexoside
51	17.707		619.4214 [M + H]+	641.4061 [M + Na]+ 601.4132 [M + H − H2O]+ 583.3962 [M + H − 2H2O]+ 439.3566 [M + H − 162 − H2O]+; 421.343 [M + H − 162 − 2H2O]+ 403.3362	617.3951 [M − H]−	663.3966 [M + HCOO]− 265.1462		Unidentified-O-hexoside

^a Compared with standard compound.

, together with the corresponding retention time, UV λ_max, pseudo-molecular ion, and main fragment ions in MS². The total ion chromatograms obtained from the positive (A) and negative (B) ions are shown in Figure 3. Based on the present UPLC separation and the evaluation of the MS/MS spectra, ME was found to contain a great variety of polyphenolic compounds, including phenolic acids, flavonoids, isoflavones, and pterocarpans, as well as other unidentified compounds with defined UV λ_max and MS fragment characteristics. Fifty-one peaks have been detected by removing the impurity and low signal-to-noise ratio peaks, and 31 compounds among them have been characterized and identified, and their structures are presented in Figure S1.

2.3.1. Phenolic Acids

Peaks 1, 2, 3, and 9 all exhibited the typical fragment ion of [M − H − CO₂], as well as the UV λ_max at 290–320 nm, suggesting that they could be the phenolic acids. According to the literature [21,22] and reference products, peaks 1 and 2 were identified as benzoic acid derivative vanillic acid and protochatechuic acid, respectively. Peak 3 was identified as caffeic acid by comparison with the reference compound. Peak 9 showed a quasi-molecular ion at m/z 193.0515 ([C₁₀H₉O₄]⁻), which further generated fragment ions at m/z 178.0311 ([C₉H₆O₄]⁻) and 134.0392 ([C₈H₆O₂]⁻) by losing CH₃ or both CH₃ and CO₂ groups. Unequivocally, it was identified as ferulic according to the reference [23] and standard compound.

2.3.2. Flavonoids

Peaks 6, 7, 8, 11, 12, 15, 22, and 25 all exhibited the typical UV profile of flavonol with the λ_max value ranging between 255 and 350 nm, and the aglycone ion at m/z 303 and product ion at m/z 287 were also found in their MS/MS spectrum. These characteristic ion rules were very useful for screening flavonoids, and the flavone aglycone (25) was characterized as quercetin by comparison with the reference compound. Neutral losses of [M + H − rha]⁺ (m/z 465.0987) and [M + H − glc − rha]⁺ (m/z 303.0524) were exhibited for peak 7, which was identified as rutin by comparing it to the reference compound and the literature [24]. Peaks 11 and 12 all presented the quasi-molecular ion at m/z 465.10 and the neutral loss of [M + H − 162]⁺ (loss of hexosyl unit), and they were characterized as hyperoside and isoquercitrin, respectively, according to the previous reports [25,26] and reference compounds. Peak 6 and 8 all showed similar quasi-molecular ions at m/z 597.1486 [M + H]⁺ and the fragment ions of [M + H − 132]⁺ (m/z 465.1012) and [M + H − 132 − 162]⁺ (303.0500) by the losses of the pentosyl unit or both pentosyl and hexosyl units, respectively. However, the exact nature of the sugars and the position of linkages between glycosides could not be ascertained. Thus, these two compounds were only tentatively assigned as quercetin-O-hexoside-pentoside. Similarly, peak 22 was tentatively identified as quercetin-O-hexoside- rutinoside due to the presence of the ions of [M + H]⁺ (m/z 773.2129), [M + H − 162]⁺ (m/z 611.6411), [M + H − 162 − 146]⁺ (m/z 465.1052), and [M + H − 162 − 146 − 162]⁺ (m/z 303.0500). Peak 15 yielded a quasi-molecular ion [M − H]⁻ at m/z 549.0860, releasing an MS² fragment at m/z 301 [M − H − 162 − 86]⁻, which might correspond to the loss of a malonyl-hexoside moiety. Therefore, peak 15 was tentatively assigned as quercetin-O-malonyl-hexoside.

Peaks 13, 14, 17, 27, and 36 all produced positive ions at m/z 317 and m/z 303, which were similar to those generated by isorhamnetin, according to the literature [27]. Thus, peak 36 could be tentatively identified as isorhamnetin, and the other peaks could be assigned as the glycosylated derivatives of isorhamnetin, owing to the neutral losses of sugar moieties being observed in their MS² spectrum. For peak 13, the pseudo-molecular ion peak at m/z 647.1636 [M + Na]⁺ and fragment ions of [M + H − rha]⁺ (m/z 479.1188) were found, and it was identified as isorhamnetin-3-O-rutinoside by comparing mass spectra with data from the literature [27]. Similarly, peak 17 was identified as isorhamnetin-3-O-β-d-glucoside owing to the presence of [M + H − 162]⁺, which has been confirmed by the reference compound. Considering the common fragments at m/z 317 ([isorhamnetin + H]⁺) and m/z 479 ([isorhamnetin + H + 162]⁺) generated by both peaks 14 and 27, peak 27 was tentatively assigned as isorhamnetin-O-hexoside due to the presence of the quasi-molecular ion of [M + H]⁺ at m/z 479.1185, and peak 14 was assigned as an isorhamnetin-O-hexoside derivative.

Peak 16 ([M + H]⁺ at m/z 449) released a fragment at m/z 287 [M + H − 162]⁺, which was similar to that of compound 33, suggesting that compound 16 could be a glycosylated derivative of compound 33. By comparison with the commercial standards, peaks 16 and 33 were identified as astragalin and kaempferol, respectively.

Peaks 30, 31, and 34 were assigned as glycosylated derivatives of rhamnocitrin, according to the common fragment at m/z 301.07 [rhamnocitrin + H]⁺, as well as the UV profile with peak 49, which was identified as rhamnocitrin with the reference standard. The compound corresponding to peak 31 was hypothesized as rhamnocitrin-O-hexoside, considering its pseudo-molecular ion at m/z 463 and the fragment at m/z 301 ([M + H − hexosyl]⁺). Peak 34 exhibited the pseudo-molecular ion at m/z 549, which suggested the presence of a malonylhexoside moiety ([rhamnocitrin + H + 162 + 86]⁺), thus the compound corresponding to peak 31 was hypothesized as rhamnocitrin-O-hexoside-malonate. Peak 30, in turn, should correspond to rhamnocitrin-malonylhexoside-rhamnoside, considering the pseudo-molecular ion at m/z 695 and the fragment at m/z 549 ([M + H − 146]⁺), m/z 463 ([M + H − 146 − 86]⁺), and m/z 301([M + H − 146 − 86 − 162]⁺). All these data were consistent with those reported in the literature [28].

2.3.3. Isoflavones

Compound 10 yielded a [M + H]⁺ ion at m/z 447.1312 and a major product ion at m/z 285.0738, and showed a loss of 162 Da, which was deduced to occur via the loss of a glucoside moiety. It was unambiguously identified as calycosin-7-O-β-d-glucoside, which was confirmed by the comparison of its t_R and mass data with the reference standard. Compound 26 ([M + H]⁺ at m/z 285.0756) could release the ion at m/z 270.0500 as the predominant fragmentation due to the loss of a methyl unit. Finally, this compound was identified as calycosin by comparing its mass spectra with the data of the literature [29] and reference compound. The MS spectrum of peak 19 showed [M + H]⁺ at m/z 463.1234 and fragment ions of [M + H − glc]⁺ at m/z 301.0672 and [M + H − glc − CH₃]⁺ at m/z 286.1731. It was identified as pratensein-7-O-β-d-glucoside by comparing the MS data with the literature [28].

2.3.4. Pterocarpans

The [M + H]⁺ ion of compound 28 at m/z 463.1592 produced the aglycone ion at m/z 301.0672 in the MS² spectrum, which originated from the neutral loss of a glucose moiety (162 Da). This compound was unambiguously identified as (−)-methylinissolin 3-O-β-d-glucoside (9,10-diMP-3-O-glucoside) by comparing its t_R values and mass spectra with the data of the literature [28] and reference standard. Compound 35 displayed a similar pattern with compound 28, despite an additional loss of 42 Da, suggesting the presence of an acetyl-glucose moiety. Thus, this compound was tentatively assigned as 9, 10-diMP-3-O-acetyl-glucoside.

2.3.5. Saponins

Peak 38 produced the typical ions of m/z 827.4484 [M + H]⁺ and m/z 825.4608 [M − H]⁻, which indicated that its molecular weight was 826 (C₄₃H₇₀O₁₅). In addition, m/z 647.3793 [M + H − glc]⁺ and m/z 629.3701 [M + H − glc − H₂O]⁺ were also found. The compound was identified as isoastragaloside II by comparing the MS data of literature [30] and reference compound. Compound 47 (m/z 913.5197 [M + H]⁺) exhibited a similar pattern with compound 38, despite an additional loss of 86 Da, indicating the presence of a malonyl unit. Thus, this compound was tentatively deduced as a malonylastragaloside II isomer.

Compounds 48 showed a molecular ion [M + Na]⁺ and [M + H]⁺ at m/z 965.5129 and 943.5306, respectively. Other important fragments in the spectrum were at m/z 97.4725 [M + H − rha]⁺, m/z 635.4149 [M + H − glc − rha]⁺, m/z 617.4098 [M + H − glc − rha − H₂O]⁺, and m/z 599.3946 [M + H − glc − rha − 2H₂O]⁺. This compound was deduced as soyasaponin I according to the literature [21], which was confirmed by comparing it with the reference standard.

2.3.6. Unknown Compounds

The structure of the compounds marked as unidentified (18, 23, 24, 39, 40, 41, 43, 44, 45) has not yet been revealed. Among the unidentified-O-hexoside-hexoside (4), unidentified-O-hexosides (5, 32, 50, 51), unidentified-O-rhamnosides (29, 42, 46), and unidentified-O-pentoside (37), only the presence, type, and the linkage of the sugar moiety could be evidenced.

Some peaks (19 and 20) could not be identified currently, while they showed UV absorption in two regions, 240–260 nm and 340–370 nm, indicating the existence of multi-conjugated systems in their chemical constituents [31], which conforms to the characteristics of flavonoid compounds. Thus, we speculate that the above compounds may be flavonoid derivatives.

2.4. Quantification of Target Compounds in AMF Extract by UPLC-TQ-MS/MS

To reveal the contents of the phenolic acids and flavonoids compounds in different extracts of AMF, a UPLC-TQ-MS/MS method was established and a total of 16 polyphenols, including four phenolic acids and 12 flavonoids, were simultaneously determined. The validation of the proposed method was performed by determining the linearity, LOD, LOQ, precision, repeatability, stability, and recovery, and the results are shown in Table S1 and Table S2. All the marker substances showed good linearity, with the determination coefficients (R²) ranging from 0.9917 to 0.9999 in a relatively wide concentration range. The results of precision, repeatability, and stability tests of the 16 analytes were less than 4.85%, and the recoveries of the analyzed compounds were 95.31–102.10%, with RSDs less than 4.73%. The above results suggested that the proposed method is accurate, precise, and sensitive enough for a quantitative evaluation of those bioactive components in AMF extracts.

The established UPLC–TQ-MS/MS method was then subsequently applied to simultaneous determination of phenolic acids (protochatechuic acid, caffeic acid, vanillic acid, ferulic acid) and flavonoids (rutin, calycosin-7-O-β-d-glucoside, hyperoside, astragalin, isorhamnetin-3-O-β-d-glucoside, (−)-methylinissolin-3-O-β-d-glucoside, quercetin, calycosin, kaempferol, isorhamnetin, formononetin, rhamnocitrin) in AE, EE, LE, ME, and HE samples of AMF. The results (

Table 2. The contents (mg/g) of 16 investigated compounds in extracts of AMF.

Analytes	Samples
	AE	EE	LE	ME	HE
protochatechuic acid	0.169 ± 0.026	0.390 ± 0.093	0.385 ± 0.004	0.322 ± 0.015	nd a
caffeic acid	nd	0.053 ± 0.008	nd	0.226 ± 0.004	nd
vanillic acid	0.134 ± 0.004	0.267 ± 0.039	nd	0.755 ± 0.008	0.017 ± 0.001
ferulic acid	0.064 ± 0.001	0.176 ± 0.024	nd	0.568 ± 0.015	nd
rutin	0.663 ± 0.021	1.952 ± 0.162	nd	6.099 ± 0.080	0.018 ± 0.001
calycosin-7-O-β-d-glucoside	nd	0.024 ± 0.002	nd	0.048 ± 0.001	nd
hyperoside	4.669 ± 0.510	6.574 ± 0.292	nd	16.285 ± 0.195	nd
astragalin	1.063 ± 0.073	1.674 ± 0.026	nd	4.810 ± 0.028	0.042 ± 0.002
isorhamnetin 3-O-β-d-glucoside	1.673 ± 0.055	2.326 ± 0.128	0.0139 ± 0.001	4.970 ± 0.048	0.079 ± 0.003
(−)-methylinissolin 3-O-β-d-glucoside	0.219 ± 0.016	0.322 ± 0.005	nd	0.838 ± 0.027	0.044 ± 0.002
quercetin	0.133 ± 0.017	1.159 ± 0.029	0.018 ± 0.001	2.295 ± 0.038	1.326 ± 0.055
calycosin	nd	0.095 ± 0.006	nd	0.086 ± 0.002	4.558 ± 0.073
kaempferol	nd	0.141 ± 0.016	0.025 ± 0.001	0.088 ± 0.002	0.562 ± 0.017
isorhamnetin	0.009 ± 0.001	0.142 ± 0.006	nd	0.042 ± 0.001	0.551 ± 0.006
formononetin	nd	0.020 ± 0.001	nd	nd	0.110 ± 0.001
rhamnocitrin	0.022 ± 0.005	1.425 ± 0.096	nd	0.224 ± 0.008	2.184 ± 0.053
Total content of phenolic acids	0.367 ± 0.011	0.886 ± 0.058	0.385 ± 0.012	1.871 ± 0.026	0.017 ± 0.002
Total content of flavonoids	8.451 ± 0.523	16.973 ± 0.854	0.057 ± 0.004	36.399 ± 1.230	10.801 ± 0.452

^a not detected.

) showed that there were remarkable differences among the contents of the 16 target compounds in different extracts of AMF. EE has higher contents of phenolic acids (0.886 ± 0.058 mg/g) and flavonoids (16.973 ± 0.854 mg/g) than AE. ME was found to be the richest of phenolic acids (1.871 ± 0.026 mg/g) and flavonoids (36.399 ± 1.230 mg/g), which were far more than those in LE and HE. As for the individual compounds in ME, hyperoside was found to be the predominant constituent with the content of 16.285 ± 0.195 mg/g, nearly one half of the total content of flavonoids analyzed in the assay, followed by rutin (6.099 ± 0.080 mg/g), isorhamnetin-3-O-β-d-glucoside (4.970 ± 0.048 mg/g), and astragalin (4.810 ± 0.028 mg/g). Compared with ME, HE mainly contained the flavone aglycones, such as calycosin, rhamnocitrin, and quercetin with the contents of 4.558 ± 0.073 mg/g, 2.184 ± 0.053 mg/g, and 1.326 ± 0.055 mg/g, respectively. While for LE, only four analytes were detected with a total content of less than 0.5 mg/g. Owing to the fact that the total content of flavonoids was significantly higher than the total content of phenolic acids in AMF extracts, it indicates that the flavonoids with reliable biological activities might be representative and abundant compounds of AMF.

2.5. Correlation Matrix Analysis

In order to better appreciate the relationships among the antioxidant capacities, TPC, TFC, and the contents of 16 quantitative compounds, Pearson’s correlation coefficients were calculated and the results are summarized in (

Table 3. Pearson’s correlation coefficients of antioxidant activities with phenolic acids and flavonoids contents for AMF.

Analytes	DPPH	ABTS	FRAP
TPC a	0.658 *	0.713 **	0.805 **
TFC	0.717 **	0.750 **	0.948 **
protochatechuic acid	0.181	0.320	0.514
caffeic acid	0.785	0.776	0.980 **
vanillic acid	0.691 *	0.691 *	0.953 **
rutin	0.684 *	0.677 *	0.946 **
calycosin-7-O-β-d-glucoside	0.773	0.756	0.974 **
hyperoside	0.737 *	0.678 *	0.960 **
ferulic acid	0.739 *	0.684 *	0.963 **
astragalin	0.679 *	0.669 *	0.944 **
isorhamnetin-3-O-β-d-glucoside	0.672 **	0.660 **	0.943 **
(−)-methylinissolin-3-O-β-d-glucoside	0.675 *	0.670 *	0.949 **
quercetin	0.575 *	0.604 *	0.872 **
calycosin	−0.278	−0.189	−0.186
kaempferol	0.022	0.097	0.067
isorhamnetin	−0.190	−0.048	−0.027
formononetin	−0.018	−0.074	0.338
rhamnocitrin	−0.168	−0.017	−0.004

^a TPC, TFC: total phenols and flavonoids contents, respectively; DPPH, ABTS: DPPH radical scavenging activity at 166.7 μg/g, 74.1 μg/g, and 32.9 μg/g, and ABTS radical scavenging activity at 100 μg/g, 44.4 μg/g, and 29.8 μg/g, respectively; FRAP: ferric reducing antioxidant power was expressed as μM Fe²⁺ equivalent expression of 2 mg, 1 mg, and 0.4 mg dry extract, respectively. * Significant at p < 0.05. ** Significant at p < 0.03.

).

Strong relationships (r 0.658 to 0.948) [32] were observed between the antioxidant capacity (DPPH, ABTS, and FRAP) and the TPC and TFC in AMF extracts. This finding indicated that the antioxidant activities most probably might be contributed by polyphenols contents in AMF, which was in agreement with the previous reports [33].

As for the individual compounds, the phenolic acids, except caffeic acid, showed strong relationships (r from 0.785 to 0.980) with the antioxidant capacities. The flavone glycosides exhibited a higher correlation with the antioxidant capacities than the aglycones. For example, isorhamnetin-3-O-β-d-glucoside was highly correlated with DPPH, ABTS, and FRAP (r = 0.672, r = 0.660, r = 0.943, respectively), while the correlation coefficients of its aglycone isorhamnetin with DPPH, ABTS, and FRAP were only −0.190, −0.048, and −0.027, respectively. A similar phenomenon was also found between calycosin-7-O-β-d-glucoside and calycosin. However, Pietta [34] demonstrated that the presence of a hydroxyl group in the heterocyclic ring also increases the radical-scavenging activity, while glycosylation greatly reduces the radical-scavenging. The change of antioxidant ability caused by the interaction of many compounds may be one of the reasons for the strong antioxidant ability of glycosides. In addition, the number of phenolic hydroxyl groups in aglycones is also an important index affecting their antioxidant activity, which is consistent with earlier reports [35,36]. This phenomenon was confirmed by the higher correlations of quercetin with antioxidant capacities than those of kaempferol, formononetin, and isorhamnetin.

3. Materials and Methods

3.1. Chemicals and Materials

Fresh AMF samples were collected from two-year-old cultivation A. membranaceus var. mongholicus plants in Hunyuan County (Shanxi, China), July 2016, and originally identified by Prof. Jin-ao Duan, Nanjing University of Chinese Medicine. In the local area, AMF was dried in shade, crushed into fine powder (40 mesh), and preserved under −20 °C protection from light for analysis.

Butylated hydroxytoluene (BHT), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,4,6-tri (2-pyridyl)-striazine (TPTZ), iron (III) chloride, and Folin-Ciocalteu reagent were purchased from Sigma-Aldrich (city, state abbreviation, USA.). Sodium acetate trihydrate, iron (II) sulfate hepta-hydrate, hydrochlorid acid, and sodium carbonate were from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China). Phosphate buffer and ethanol were purchased from WuXi ChemicalWorks (WuXi, Jiangsu, China). Acetonitrile and methanol were HPLC-grade from Merck (Darmstadt, Germany). Ultra-pure water was prepared by a Millipore Direct Q5 purification system (Millipore, Bedford, MA, USA). AB-8 macroporous resin was purchased from Solarbio (Beijing, China). All other used chemicals were of analytical grade (Nanjing Chemical Plant, Nanjing, China).

Chemical standards, including protochatechuic acid, caffeic acid, vanillic acid, rutin, calycosin-7-O-β-d-glucoside, hyperoside, ferulic acid, astragalin, isorhamnetin-3-O-β-d-glucoside, (−)-methylinissolin-3-O-β-d-glucoside, quercetin, calycosin, kaempferol, isorhamnetin, formononetin, soyasaponin I, rhamnocitrin, and chlorogenic acid, were purchased from Nanjing LongWave biological science and technology Co. Ltd. (Nanjing, China). The purity of each reference compound was over 98%, as determined by HPLC analysis.

3.2. Preparation of Plant Extracts

Three samples of AMF powder (40 mesh), each 300.0 g, were taken and accurately weighed. One of them was extracted with water (3 L, 3 × 60 min) in an ultrasonic bath at room temperature, and the combined filtrates were concentrated under reduced pressure at 65 °C, and concentrated solution was frozen at −80 °C overnight and then freeze-dried using a Labconco FreeZone (5 L, Kansas City, MO, USA). The drying was conducted at 0.04 mbar of vacuum, with a drying temperature programmed from −30 to 25 °C. The drying time was 72 h. As a result, a total of 96.0 g aqueous extract (AE) with a water content less than 10% was obtained. The other sample was extracted with ethanol (3 L, 3 × 60 min) and was subsequently processed as the above procedure to obtain the sample of ethanol extract (EE) of 125.4 g. The last one was extracted with ethanol (3 L, 3 × 60 min) in an ultrasonic bath at room temperature, and the combined filtrates were concentrated to 200 mL under reduced pressure at 55 °C. Then, the ethanol-removed solution was separated by an AB-8 macroporous resin column (7.0 cm × 80 cm) eluted with different ratios (10%, 50%, and 90%, v/v) of ethanol in water, respectively, until each gradient effluent was colorless. Subsequently, the eluents were condensed and dried using a freeze dryer to obtain the samples of LE (freeze-dried powder of 10% eluent) 60.5 g, ME (freeze-dried powder of 50% eluent) 9.3 g, and HE (freeze-dried powder of 90% eluent) 6.9 g, with a water content of less than 10%, respectively. All the dry extracts were stored at 4 °C until used.

3.3. Antioxidant Assays

Each dry extract was dissolved in 80% methanol at a concentration of 2 mg/mL and then diluted to prepare the series of concentrations for antioxidant assays, which were performed on an Enspire multifunctional enzyme labeling instrument (Perkin Elmer, Foster City, CA, USA) at the respective wavelengths. All measurements were run in triplicate. The respective antioxidant capacity parameters were also determined for the reference compound BHT as the positive control. All analyses were realized as much as possible in an area protected against light.

3.3.1. DPPH Radical Scavenging Activity Assay

The DPPH free radical scavenging activity of the AMF extracts was measured according to the method of Dong et al. [37]. The reaction mixture was shaken and incubated in the dark at room temperature for 30 min, and the absorbance was read at 517 nm against the blank. The DPPH radical scavenging percentage (%) was calculated using the formula: [1 − (A₁ − A₂)/A₃] × 100%, where A₁ is the absorbance of reaction mixture, A₂ is that of the sample only in the absence of DPPH, and A₃ is the absorbance of the control reaction (containing all reagents except the test sample).

3.3.2. ABTS Radical Scavenging Assay

The ABTS assay of the fractions from AMF was performed as reported previously [38], and the absorbance was read at 734 nm after 6 min incubation. The ABTS radical scavenging percentage (%) was calculated using the formula: [1 − (A₁ − A₂)/A₃] × 100%, where A₁ is the absorbance of reaction mixture, A₂ is that of the sample only in the absence of ABTS solution, and A₃ is the absorbance of the control reaction only without sample.

3.3.3. Ferric Reducing Antioxidant Potential (FRAP) Assay

The FRAP assay was conducted according to the method in the literature [38], and the absorbance was measured at 593 nm. The FRAP results were expressed as μmol Fe²⁺ equivalents per gram of dried extracts (μmol Fe²⁺/mg). All measurements were done in triplicate.

3.4. Total Phenols (TPC) and Flavonoids Contents (TFC) Quantification

TPC was determined by the Foline–Ciocalteu method [39] and the result was expressed as milligrams of chlorogenic acid equivalents per gram of dry weight (mg CAE/g dw). TFC was determined by an aluminum nitrate colorimetric assay using rutin as a reference compound, as described in the literature [40], and the result was expressed as milligrams of rutin equivalents per g of dried fraction (mg RE/g dw).

3.5. Identification of the Compounds in AMF Extracts by UPLC-Q-TOF/MS

The dry powder (0.1 g) of ME was re-dissolved in 20 mL of 80% (v/v) methanol aqueous solution, then the solution was filtered through a 0.22 μm micropore membrane before UPLC-QTOF-MS analysis. Chromatography was performed on an Acquity™ UPLC system (Waters Corp. Milford, MA, USA) equipped with a diode array detector coupled to an electrospray ionization mass detector (UPLC-DAD-ESI/MSⁿ). The separation was carried out on an Acquity UPLC^TM BEH C18 column (100 mm × 2.1 mm i.d. 1.7 μm; Waters Corp. Milford, MA, USA) maintained at 35 °C. The mobile phase consisted of 0.1% formic acid (HCOOH) in water as solvent A and acetonitrile (ACN) as solvent B, with a gradient elution as follows: 0–9 min, 5–26% B; 9–19 min, 26–65% B; 19–27 min, 65–95% B; 27–27.5 min, 65–95% B; 27.5–30 min, 95–95% B. The flow rate was 0.4 mL/min. The sample injection volume was 3 μL.

Mass detection was performed in positive and negative electrospray modes, using a Synapt^TM Q-TOF MS (Waters, Manchester, UK). The gas (N₂) flows of the cone and desolvation were 50 and 700 L/h, respectively. The temperature of the ion source was maintained at 120 °C and the desolvation temperature was 350 °C. The full scan spectrum was from 100 to 1500 Da. All data collected in centroid mode were acquired and processed using MasslynxNT 4.1 software (Waters Corp. Milford, MA, USA) for peak detection. All analyses were acquired using leucine-enkephalin (ESI⁺: m/z 556.2771, ESI⁻: m/z 554.2615) as the lock spray to ensure accuracy and reproducibility.

The compounds were identified by comparing their retention times, UV, and mass spectra with those obtained from reference compounds, when available. Otherwise, compounds were tentatively identified by comparing the obtained information with available data reported in the literature.

3.6. Quantification of the Compounds in in AMF Extracts by UPLC-TQ-MS/MS

Analysis was performed on a UPLC-MS/MS system (ACQUITY UPLC, Xevo TQ tandem quadrupole mass spectrometer; Waters Corporation; Milford, MA, United States). About 0.1 g of AMF extract was weighed accurately into a 10 mL volumetric flask and dissolved with 80% methanol to the scale, followed by centrifugation at 4 °C (15,000× g, 10 min). The supernatant solution was diluted 10 times with 80% methanol solvent, and the original solution and the diluted sample solution were then filtered through a 0.22 mm filter, respectively. A total of 1 μL of samples was injected into an Acquity UPLC BEH C18 (2.1 mm × 100 mm, 1.7 μm) column using 0.1% formic acid in water (A) and acetonitrile (B) as mobile phase, with the gradient elution as follows: 0–1 min, 5–15% B; 1–14 min, 15–70% B. The flow rate was kept at 0.40 mL/min and the column temperature was maintained at 35 °C throughout the analysis.

The triple quadrupole (TQ) mass spectrometer was operated in both positive and negative modes. The cone voltage and collision energy were optimized for each analyte and selected values are shown in Table S3, and the UPLC–MS/MS chromatography of 16 markers is presented in Figure S2. The raw data were acquired and processed with MassLynx 4.1 software (Waters Corporation, Milford, MA, USA).

Validation of the method was performed as described in the Supplementary Material. Concentrations of the target compounds were calculated from the peak areas of the sample and the corresponding standards.

3.7. Statistical Analysis

All experiments were carried out in triplicate and results were expressed in means ± standard deviation (SD). One-way analysis of variance (ANOVA) was applied to compare data and the significance of the difference was statistically considered at the level of p < 0.05. Relationships between parameters were determined by Pearson’s correlation test. All the analyses were performed with the software of SPSS v. 20. 0 (IBM Corp, Chicago, IL, USA).

4. Conclusions

To the best of our knowledge, this work is the first study on total phenols and flavonoids composition combined with the antioxidant activity of AMF. As it was initially proposed, AMF presented the total phenolic and flavonoids profiles, as well as the antioxidant capacity, which may allow these botanical parts to be considered as high value by-products. The ME, a chemical fraction obtained from AMF, exhibited strong antioxidant activity, and was rich in phenolic acids and flavonoids. Overall, the clarification of their phytochemical profile and activity in this research provides useful information for the utilization of the by-product of Astragalus membranaceus var. mongholicus.